Browsing Tag
IMPT-314
1 post
Lyell Immunopharma to acquire ImmPACT—are CAR T-cell therapies the future of oncology?
Lyell Immunopharma is making waves with its strategic acquisition of ImmPACT Bio, a move aimed at bolstering its…